Literature DB >> 21447599

Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.

Surya A Reis1, Morgan N Thompson, Jong-Min Lee, Elisa Fossale, Hyung-Hwan Kim, James K Liao, Michael A Moskowitz, Stanley Y Shaw, Linda Dong, Stephen J Haggarty, Marcy E MacDonald, Ihn Sik Seong.   

Abstract

The expanded CAG repeat that causes striatal cell vulnerability in Huntington's disease (HD) encodes a polyglutamine tract in full-length huntingtin that is correlated with cellular [ATP] and [ATP/ADP]. Since striatal neurons are vulnerable to energy deficit, we have investigated, in Hdh CAG knock-in mice and striatal cells, the hypothesis that decreased energetics may affect neuronal (N)-cadherin, a candidate energy-sensitive adhesion protein that may contribute to HD striatal cell sensitivity. In vivo, N-cadherin was sensitive to ischemia and to the effects of full-length mutant huntingtin, progressively decreasing in Hdh(Q111) striatum with age. In cultured striatal cells, N-cadherin was decreased by ATP depletion and STHdh(Q111) striatal cells exhibited dramatically decreased N-cadherin, due to decreased Cdh2 mRNA and enhanced N-cadherin turnover, which was partially normalized by adenine supplementation to increase [ATP] and [ATP/ADP]. Consistent with decreased N-cadherin function, STHdh(Q111) striatal cells displayed profound deficits in calcium-dependent N-cadherin-mediated cell clustering and cell-substratum adhesion, and primary Hdh(Q111) striatal neuronal cells exhibited decreased N-cadherin and an abundance of immature neurites, featuring diffuse, rather than clustered, staining for N-cadherin and synaptic vesicle markers, which was partially rescued by adenine treatment. Thus, mutant full-length huntingtin, via energetic deficit, contributes to decreased N-cadherin levels in striatal neurons, with detrimental effects on neurite maturation, strongly suggesting that N-cadherin-mediated signaling merits investigation early in the HD pathogenic disease process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447599      PMCID: PMC3098733          DOI: 10.1093/hmg/ddr127

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  59 in total

Review 1.  Small GTPases and regulation of cadherin dependent cell-cell adhesion.

Authors:  V M Braga
Journal:  Mol Pathol       Date:  1999-08

2.  HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.

Authors:  Ihn Sik Seong; Elena Ivanova; Jong-Min Lee; Yeun Su Choo; Elisa Fossale; MaryAnne Anderson; James F Gusella; Jason M Laramie; Richard H Myers; Mathieu Lesort; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

Review 3.  Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton.

Authors:  Marita Goodwin; Alpha S Yap
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

4.  Temporally distinct demands for classic cadherins in synapse formation and maturation.

Authors:  Ozlem Bozdagi; Martin Valcin; Kira Poskanzer; Hidekazu Tanaka; Deanna L Benson
Journal:  Mol Cell Neurosci       Date:  2004-12       Impact factor: 4.314

Review 5.  Cadherins: actin with the cytoskeleton to form synapses.

Authors:  Shernaz X Bamji
Journal:  Neuron       Date:  2005-07-21       Impact factor: 17.173

6.  Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.

Authors:  V C Wheeler; W Auerbach; J K White; J Srinidhi; A Auerbach; A Ryan; M P Duyao; V Vrbanac; M Weaver; J F Gusella; A L Joyner; M E MacDonald
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

7.  Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases.

Authors:  Marisa D Covington; Kayla J Bayless; Robert C Burghardt; George E Davis; Alan R Parrish
Journal:  Am J Physiol Renal Physiol       Date:  2005-03-15

8.  Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels.

Authors:  Leigh Anne Swayne; Lina Chen; Shahid Hameed; Wendy Barr; Emily Charlesworth; Michael A Colicos; Gerald W Zamponi; Janice E A Braun
Journal:  Mol Cell Neurosci       Date:  2005-09-12       Impact factor: 4.314

9.  Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.

Authors:  Carsten Saft; Jochen Zange; Jürgen Andrich; Klaus Müller; Katrin Lindenberg; Bernhard Landwehrmeyer; Matthias Vorgerd; Peter H Kraus; Horst Przuntek; Ludger Schöls
Journal:  Mov Disord       Date:  2005-06       Impact factor: 10.338

Review 10.  Regulation of cadherin adhesive activity.

Authors:  B M Gumbiner
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

View more
  15 in total

Review 1.  Phenotyping patient-derived cells for translational studies in cardiovascular disease.

Authors:  Stanley Y Shaw; Ari D Brettman
Journal:  Circulation       Date:  2011-11-29       Impact factor: 29.690

2.  The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity.

Authors:  Zih-Ning Huang; Lu-Shiun Her
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

3.  Mutant huntingtin impairs immune cell migration in Huntington disease.

Authors:  Wanda Kwan; Ulrike Träger; Dimitrios Davalos; Austin Chou; Jill Bouchard; Ralph Andre; Aaron Miller; Andreas Weiss; Flaviano Giorgini; Christine Cheah; Thomas Möller; Nephi Stella; Katerina Akassoglou; Sarah J Tabrizi; Paul J Muchowski
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

4.  Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.

Authors:  Mahru C An; Ningzhe Zhang; Gary Scott; Daniel Montoro; Tobias Wittkop; Sean Mooney; Simon Melov; Lisa M Ellerby
Journal:  Cell Stem Cell       Date:  2012-06-28       Impact factor: 24.633

5.  An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.

Authors:  Valentina Lo Sardo; Chiara Zuccato; Germano Gaudenzi; Barbara Vitali; Catarina Ramos; Marzia Tartari; Michael A Myre; James A Walker; Anna Pistocchi; Luciano Conti; Marta Valenza; Binia Drung; Boris Schmidt; James Gusella; Scott Zeitlin; Franco Cotelli; Elena Cattaneo
Journal:  Nat Neurosci       Date:  2012-05       Impact factor: 24.884

6.  Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease.

Authors:  Sreedevi Chandrasekaran; Danail Bonchev
Journal:  Comput Struct Biotechnol J       Date:  2016-02-10       Impact factor: 7.271

7.  Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease.

Authors:  Elisabeth Singer; Carolin Walter; Jonasz J Weber; Ann-Christin Krahl; Ulrike A Mau-Holzmann; Nadine Rischert; Olaf Riess; Laura E Clemensson; Huu P Nguyen
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

Review 8.  Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells.

Authors:  Kalina Wiatr; Wojciech J Szlachcic; Marta Trzeciak; Marek Figlerowicz; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

9.  Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.

Authors: 
Journal:  Cell Stem Cell       Date:  2012-06-28       Impact factor: 24.633

10.  Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.

Authors:  Karen L Ring; Mahru C An; Ningzhe Zhang; Robert N O'Brien; Eliana Marisa Ramos; Fuying Gao; Robert Atwood; Barbara J Bailus; Simon Melov; Sean D Mooney; Giovanni Coppola; Lisa M Ellerby
Journal:  Stem Cell Reports       Date:  2015-12-08       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.